PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193438
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193438
Molecular Cytogenetics Market size was valued at USD 2,309.1 Million in 2022, expanding at a CAGR of 10.2% from 2023 to 2030.
Combining molecular biology and cytogenetics is called molecular cytogenetic. Cytogenetics is the study of chromosomes, and molecular cytogenetics is the use of in-situ hybridization methods to analyses genetic variants or modifications. Biology and medicine both heavily rely on the applications of molecular cytogenetics. The study of genomic variants, expression and evolution, chromosomal abnormalities, and chromosomal abnormalities, particularly in the context of medical and cancer genetics, is known as molecular cytogenetics.
Market Dynamics
The molecular cytogenetics market has been considerably pushed by rising cancer mortality rates and the associated increase in cancer incidence. The ongoing increase in cancer cases has highlighted the requirement for the creation of cutting-edge technology for a thorough understanding of cancer at the genomic level. As numerous cytogenetic methods have been effectively used for pharmacogenomic biomarker investigations, expanding pharmacogenomics activities are predicted to have a major impact on market growth. The existence of a sizable number of published studies proving the function of cytogenetic techniques in pharmacogenomic testing shows the effectiveness of Comparative Genomic Hybridization (CGH), FISH, and sequencing technology in pharmacogenomics.
The adoption of cytogenetic techniques is directly impacted by the growth in the use of genetic information in predictive models for disease features, which in turn increases income generating. The demand for top-notch molecular cytogenetics will rise as a result of the numerous research facilities in China, India, and Japan as well as R&D facilities. Japan leads the world in contributions to the molecular cytogenetics market as a result of long-standing partnerships between businesses and academic organizations. Additionally, developed nations are beginning to recognize the value of personalized medicine in treating genetic or other illnesses, which is anticipated to drive the market throughout the forecast period. However, over the projected period, technological constraints and equipment complexity are anticipated to restrain the growth of the molecular cytogenetic market.
Segmentation Analysis:
The Global Molecular Cytogenetics Market is segmented on the basis of Product, Application, End User, and Region.
The market is split into six categories based on Product: instruments, kits and reagents, testing kits, probes, fluorescent affinity reagents, and others. The kits and reagents segment dominates the market. Growing demand for kits and reagents in molecular testing is mainly contributing to segment growth.
The market is segmented into four categories based on application: Oncology, Genetic Disorders, Personalized Medicines, and Others. The genetic disorders segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the need for molecular cytogenetics in genetic disorders treatment.
The market is segmented into two categories based on End User: pharmaceuticals and biotechnology companies, clinical and diagnostic laboratories, academic research. The clinical and diagnostic laboratories segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the clinical research activities, boosting the segment growth.
Competitive Landscape:
The worldwide market for molecular cytogenetics is fairly fragmented in nature which consist of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new research projects, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in August 2023 - Agilent Technologies Inc. announced that it has acquired Polymer Standards Service GmbH (PSS) a provider of solutions in the field of polymer characterization.
Key features of the study:
This proposed research study on Molecular Cytogenetics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Molecular Cytogenetics market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Molecular Cytogenetics market
Impact of COVID-19 on Molecular Cytogenetics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Molecular Cytogenetics market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Molecular Cytogenetics market, we have also included competitive landscape and key innovator analysis for the Molecular Cytogenetics market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Molecular Cytogenetics market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Molecular Cytogenetics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR CYTOGENETICS MARKET KEY PLAYERS
Thermo Fisher Scientific Inc.
GeneDx
Danaher
Abbott
CytoTest Inc.
Empire Genomics
Agilent Technologies
Biological Industries
PerkinElmer Inc.
Bionano Genomics
Illumina Inc.
Sartorius AG
Precipio
Bio-RAD Laboratories Inc.
F. Hoffmann-La Roche AG
GLOBAL MOLECULAR CYTOGENETICS MARKET, BY PRODUCT
Instruments
Kits and Reagents
Testing kits
Probes
Fluorescent affinity reagents
Others
GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION
Oncology
Genetic Disorders
Personalized Medicines
Others
GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER
Pharmaceuticals and Biotechnology Companies
Clinical and Diagnostic Laboratories
Academic Research
GLOBAL MOLECULAR CYTOGENETICS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA